Sellas Life Sciences Group: Maxim Group raises target price to $40 from $30
SLS•Maxim Group raised its target price for Sellas Life Sciences Group to $40 from $30.
Related News

Sustainable consumer goods grow 4.9 times faster than conventional products since 2013, Shopify says
SHOP•

Ciena CEO Gary B. Smith reports sale of common shares worth $770,012.3736
CIEN•

GameSquare adds Marco Baccanello to board
GAME•

Root cause of US aviation shutdown not yet determined, Duffy says
LHX•

Innoviva, Inc.: Piper Sandler initiates coverage with overweight rating; price target $29
INVA•